Pomerantz LLP is investigating claims on behalf of investors of ETHZilla Corporation (“ETHZilla” or the “Company”) (NASDAQ: ETHZ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether ETHZilla and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click […]

Pomerantz LLP is investigating claims on behalf of investors of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether RxSight and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click

Pomerantz LLP is investigating claims on behalf of investors of Cogent Communications Holdings, Inc. (“Cogent” or the “Company”) (NASDAQ: CCOI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Cogent and certain of its officers and/or directors have engaged in securities fraud or other unlawful business

Pomerantz LLP is investigating claims on behalf of investors of Bgin Blockchain Limited (“Bgin” or the “Company”) (NASDAQ: BGIN).??Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com?or 646-581-9980, ext.?7980. The investigation concerns whether Bgin and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.? [Click here for

Pomerantz LLP is investigating claims on behalf of investors of Ventyx Biosciences, Inc. (“Ventyx” or the “Company”) (NASDAQ: VTYX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ventyx and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

Pomerantz LLP announces that a class action lawsuit has been filed against NowRx, Inc. (“NowRx” or the “Company”). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Global Team Will Launch Gastric Cancer Prevention Clinical Trial Stand Up To Cancer® (SU2C) and Cancer Research UK announced today new support for a dream team focused on stopping gastric cancer in its earliest stages. The extended funding for the SU2C Gastric Cancer Interception Dream Team will allow this leading group of researchers to build

GB Connections LLC today announced the completion of its leadership transition, marking a new chapter focused on long-term stability, disciplined growth and deeper customer partnership. With strengthened leadership across engineering, operations and commercial strategy, supported by expanded technical and customer-facing expertise, the company is positioned to anticipate customer needs and deliver reliable performance in a

The American Association for Medicare Supplement Insurance today announced the launch of its fully redesigned platform, MedicareSupp.org, the nation’s oldest and largest independent directory of Medicare insurance agents. The platform has been redeveloped to improve discoverability for agents and deliver a modern, user-friendly experience for Medicare-eligible consumers seeking trusted local guidance. For decades, MedicareSupp.org has

Gloo's growing platform now provides full lifecycle, digital and data-driven donor development solutions Gloo (Nasdaq: GLOO), a leading technology platform serving the faith and flourishing ecosystem, announced it has completed the acquisition of Westfall Group, Inc., a leader in major donor engagement. The transaction, which was previously announced, brings Westfall Gold, Inc., Brain Trust Creative,